First trimester prenatal diagnosis

Current Opinion in Obstetrics and Gynecology

Volumn 16, Issue 2, 2004, Pages 177-181

  Bahado Singh, Ray O ^a   Chee Cheng, Chen S ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CATHAY GENERAL HOSPITAL   (Taiwan)

Author keywords

Nasal bone; Nuchal translucency

Indexed keywords

ANEUPLOIDY; CHROMOSOME ABERRATION; CLINICAL PRACTICE; DIAGNOSTIC ACCURACY; FACIAL BONE; FETUS DISEASE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HUMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW;

EID: 1942518921     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-200404000-00014     Document Type: Review

References (41)

1. Snijders RJM, Noble P, Sebire N, et al. UK multicenter project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 1998; 352:343-346.
2. Wapner R, Thom E, Simpson JL. NICHD BUN Study Group. First trimester screening for trisomy 21 and 18. N Engl J Med 2003; 349:1405-1413. This was the first USA multicenter trial evaluating the sensitivity of first trimester screening for Down syndrome.
3. VonKaisenberg CS, Gasionek-Wiens A, Brelicki M, et al. German speaking Down syndrome screening group. Screening for trisomy 21 by maternal age, fetal nuchal translucency and maternal serum biochemistry 11-14 weeks. A German multicenter study. J Matern Fetal Neonatal Med 2002; 12:89-94.
4. Mueller F, Benattar C, Audibert F, et al. First-trimester screening for Down syndrome in France combining fetal nuchal translucency measurement and biochemical markers. Prenat Diagn 2003; 23:833-836.
5. Brizol ML, Carvalho MH, Liao AW, et al. First-trimester screening for chromosal abnormalities by fetal nuchal translucency in a Brazilian population. Ultrasound Obstet Gynecol 2001; 18:652-655.
6. Zoppi MA, Inba RM, Floris M, Monni G. Fetal nuchal translucency screening in 12495 pregnancies in Sardinia. Ultraound Obstet Gynecol 2001; 18:649-651.
7. Bindra R, Heath V, Liao A, et al. One-stop clinic for assessment of risk for trisomy 21 at 11-14 weeks: a prospective study of 15030 pregnancy. Ultrasound Obstet Gynecol 2002; 20:219-225.
8. Spencer K, Spencer CE, Power M, et al. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: A review of three years prospective experience. Br J Obstet Gynaecol 2003; 110:281-286.
9. Spencer K, Nicolaides KH. Screening for Trisomy 21 twins using first trimester ultrasound and maternal serum biochemistry in one-stop clinic: A review of three years experience. Br J Obstet Gynecol 2003; 110:276-280. Office-based first trimester screening is shown to have a high aneuploidy detection rate.
10. Wald NJ, Rish S, Hackshaw. Combining nuchal translucency and serum markers in prenatal screening for Down syndrome in twin pregnancies. Prenat Diagn 2003; 23:588-592.
11. Zoppi MA, Ibba RM, Floris M, et al. Changes in nuchal translucency thickness in normal and abnormal karyotype fetuses. Br J Obstet Gynecol 2003; 110:584-588. The first trimester nuchal translucency measurement was noted to decrease in a significant percentage of Down syndrome fetuses in repeat examinations.
12. Pandya PP, Snyders RJ, Johnson S, Nicolaides KH. Natural history of trisomy 21 fetuses with increased nuchal translucency thickness. Ultrasound Obstet Gynecol 1995; 5:381-383.
13. Shulman A, Maymen R. Mid-gestation Down syndrome screening test and pregnancy outcome among unstimulated assisted-conception pregnancies. Prenat Diagn 2003; 23:625-628.
14. Liao AW, Health V, Kametas N, et al. First trimester screening for trisomy 21 in singleton pregnancies achieved by assisted reproduction. Hum Reprod 2001; 16:1501-1504.
15. Wojdemann KR, Larsen SO, Shalmi A, et al. First trimester screening for Down syndrome and assisted reproduction: no basis for concern. Prenat Diagn 2001; 21:563-565.
16. Lai TH, Chen SC, Tsai MS, et al. First-trimester screening for Down syndrome in singleton pregnancies achieved by intrauterine insemination. J Assist Reprod Genet 2003; 20:327-331.
17. Larose C, Massoc P, Hillion Y, et al. Comparison of fetal nasal bone assessment by ultrasound at 11-14 weeks by post mortem x-ray in trisomy 21: a prospective obstetrical study. Ultrasound Obstet Gynecol 2003; 22:27-30.
18. Minderer S, Gloning KP, Henrich W, Stoger H. The nasal bone in fetuses with trisomy 21: a sonographic versus pathomorphological findings. Ultrasound Obstet Gynecol 2003; 22:16-21.
19. Cicero S, Ciarcio P, Papageorghiore A, et al. Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks gestation: an observational study. Lancet 2001; 358:1165-1167.
20. Zoppi MA, Ibba RM, Axiana C, et al. Absence of fetal nasal bone and aneuploidies at first-trimester nuchal translucency screening in unselected pregnancies. Prenat Diagn 2003; 23:496-500.
21. Cicero S, Dezerega V, Andrade E, et al. Learning curve for sonographic examination of the fetal nasal bone at 11-14 weeks. Ultrasound Obstet Gynecol 2003; 22:135-137.
22. Cicero S, Bindra R, Rembouskas G, et al. Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP A at 11-14 weeks. Prenat Diagn 2003; 23:306-310. The authors combined nasal bone measurements with other first trimester markers to further improve aneuploidy detection.
23. Caughey AB, Kuppermann M, Norton ME, Washington AE. Nuchal translucency and first trimester biochemical markers for down syndrome screening: a cost-effectiveness analysis. Am J Obstet Gynecol 2002; 187:1239-1245. This is a systematic analysis of the economic costs and medical risks versus benefits in first trimester screening.
24. Cusick W, Buchanan P, Hallahan TW, et al. Combined first-trimester versus second-trimester serum screening for Down syndrome: a cost analysis. Am J Obstet Gynecol 2003; 188:745-751.
25. Chasen ST, Skupski DW. Ethical dimensions of nuchal translucency screening. Clin Perinatal 2003; 30:95-102.
26. Bahado-Singh RO, Mendilicioglu I, Rowther M, et al. Early genetic sonogram for Down syndrome detection. Am J Obstet Gynecol 2002; 187:1235-1238. An 81.8% detection rate and a 4.8% false positive rate for Down syndrome were noted at 14-16 weeks.
27. Hyett J, Perdu M, Sharland G, et al. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study. BMJ 1999; 318:81-5.
28. Favre R, Cherify Y, Kohler M, et al. The role of nuchal translucency and ductus venous Doppler at 11-14 weeks gestation in the detection of major congenital heart defects. Ultrasound Obstet Gynecol 2003; 21:239-243.
29. Orvos H, Wayda K, Kozinsky Z, et al. Increased nuchal translucency and congenital heart defects in euploid fetuses. Eur J Obstet Gynecol 2002; 101:124-128.
30. Bahado-Singh RO, Zachary J, Wapner RJ. NICHD BUN Study Group. Elevated first trimester nuchal translucency measurement is associated with an increased risk of congenital heart defect [abstract]. Am J Obstet Gynecol 2003; 189:
31. Makrydimas G, Sotiriadis A, Ioannidia JPA. Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis. Am J Obstet Gynecol 2003; 189:1330-1335.
32. Haak MC, Twisk JWR, Bartelings MM, et al. Ductus venous flow velocities in relation to the cardiac defects in first-trimester fetuses with enlarged nuchal translucency. Am J Obstet Gynecol 2003; 188:727-737. First trimester cardiac Doppler changes are reported in fetuses with increased nuchal fluid.
33. Cheng CC, Lee FK, Lin HW, et al. Diagnosis of fetal acrania during the first trimester nuchal translucency screening for Down syndrome. Int J Gynaecol Obstet 2003; 80:139-144. This describes first trimester detection of neural tube defects.
34. Taipale PJ, Krista T, Alafuzoff I. Prenatal diagnosis of holoprosencephaly and ectopia cordis in a twin at 12 weeks gestation. Ultrasound Obstet Gynecol 2003; 21:198-200.
35. Teoh M, Meagher S. First-trimester diagnosis of micrognathia as a presentation of Pierre Robin syndrome. Ultrasound Obstet Gynecol 2003; 21:616-618.
36. Kauffmann E, Roman H, Barau G, et al. Case report: A prenatal case Jarcho-Levin syndrome diagnosed during the first trimester of pregnancy. Prenat Diagn 2003; 23:163-165.
37. Schiesser M, Holzgreve W, Lapaire O, et al. Sirenomelia, the mermaid syndrome: detection in the first trimester. Prenat Diagn 2003; 23:493-495.
38. Pannier E, Viot G, Aubry MC, et al. Congenital erythropoietic porphyria (Gunther's disease): Two cases with very early prenatal manifestation and cystic hygroma. Prenat Diagn 2003; 23:25-30.
39. LaurichesseDelmas H, Beaufrere AM, et al. First-trimester features of Fowler syndrome (Hydrocephaly-hydranencephaly proliferative vasculopathy). Ultrasound Obstet Gynecol 2002; 20:612-615.
40. Witters I, Fryns JP. First-trimester features of Fowler syndrome (Hydrocephaly-hydranencephaly proliferative vasculopathy). Ultrasound Obstet Gynecol 2003; 21:411-412.
41. Dolan SM, Shanske AL, Marion RW, Gross SJ. First-trimester diagnosis of Bartxocas-Papas syndrome (BPS) by transvaginal ultrasound: Case report and review of the literature. Prenat Diagn 2003; 23:138-142.